Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-12

Clinical Trial Update: Fisetin to Improve Vascular Function in Older Adults [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating fisetin to improve vascular function in older adults with aging-related endothelial dysfunction and arterial stiffness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fisetin (fisetin)

Snippet

Sponsor: University of Colorado, Boulder | Conditions: Aging, Endothelial Dysfunction | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING